Target antitumor drugs.

Targeted anti-tumor drugs are mostly tyrosine kinase inhibitors, mainly by imatini, both inside and outside the body. At the cellular level, it is possible to optionally inhibit the positive cell line cells phmyocytic lymphoblastic and acute lymphoblastic leukemia patients. Proliferation and apoptosis of fresh cells. In addition, imatini can inhibit the cell behavior of the growth factor, receptor stem cell factor, tyrosine kinase, and thus the growth factor and stem cell behavior. However, in the course of imatini's treatment, some patients gradually discovered that resistance to imatini was developed, mainly because of the mutation of the gene that expresses the abodase in these patients. A change in the amino acid of the lkinase that results in a change in the structure of the interaction between imatini and the genes on one side.In response to such drug resistance, a second generation kinase inhibitor was developed, such as dastatini, for the treatment of non-small cell lung cancer, selective epidermal growth factor receptor and tyrosine kinase, Efficient oral communication, reasonable expression of growth factor receptor tyrosine kinase inhibitor, etrodandrotiini and use of treatment and for treatment, Multiple targets for metastasis of cancer cells or for mesomesenchymal tumors of the intestinal tract tolerant of imatini to a distance of three levels of uninhibitors.The multi-target therapy for advanced renal cell carcinoma is the Anshan kinase inhibitor, which is a new oral type of empty tumor drug that acts on many chickens and no eight percent. On the one hand, by a 2F segment kinase activity, the signal conduction path is blocked, and the tumor proliferation is directly induced and suppressed. On the other hand, vascular endothelial growth factor receptor has always needed to activate receptor tyrosine kinase, inhibit tumor angiogenesis, and firmly inhibit tumor growth.The right soil of the five high hb receptor has been used as a supplement to antitumor treatment. The structure of the dansk jopalolos joazazza Joaquin drugs is characterized by the structure of both the cecar money or its electrons in an equal row leading to the group ester. Most of the paper miscellaneous links are more complex, usually connected to the desquamate, similar Handan and Korean double rings.
Active small molecular compounds.
Monoclonal antibody, polyclonal antibody, recombinant protein, active protein, natural protein.